| Literature DB >> 35010440 |
Katarzyna Wszołek1, Dominik Pruski2, Katarzyna Tomczyk1, Małgorzata Kampioni1, Karolina Chmaj-Wierzchowska1, Marcin Przybylski2, Maciej Wilczak1.
Abstract
The COVID-19 pandemic had a direct impact on the extent of guaranteed healthcare services. Many gynecologists', obstetricians', and midwives' offices were closed, laboratories suspended their activities, the collection of necessary tests was delayed, and women had to wait much longer for test results than they had to previously. General women's healthcare prophylactic programs were suspended or delayed. In 2020, screening financed by public funds covered less than one-seventh of the female population in Poland. As medical teams, professionals, clinicians, and scientists, we have been facing a challenge to help, protect, and care for one of the most vulnerable population groups, pregnant women. A significant part of that challenge has been in preventing the spread of severe COVID-19, along with other preventable diseases, among women who are pregnant, who are in labor, or who have recently given birth.Entities:
Keywords: COVID-19 pandemic; prenatal care; prevention and control; women’s health
Mesh:
Year: 2021 PMID: 35010440 PMCID: PMC8750331 DOI: 10.3390/ijerph19010180
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Mandatory preventative services, diagnostic tests, and medical consultations with comments regarding the pandemic state [6].
| Preventative Services, Diagnostic Tests, and Medical Consultations During Pregnancy 1 | Up to 10th Week of Pregnancy | 11th–14th Week of Pregnancy | 15th–20th Week of Pregnancy | 18th–22nd Week of Pregnancy | 21st–26th Week of Pregnancy | 24th–26th Week of Pregnancy | 27th–32nd Week of Pregnancy | 33rd–37th Week of Pregnancy | 38th–39th Week of Pregnancy | Immediately after 40 Weeks of Pregnancy |
|---|---|---|---|---|---|---|---|---|---|---|
| Physical examination | + | + | + | + | + | + | + | + | ||
| Blood pressure measurement | + | + | + | + | + | + | + | + | ||
| Mammary glands palpation | + | + | ||||||||
| BMI determination | + | |||||||||
| Pregnancy risk determination | + | + | + | + | + | + | + | + | ||
| Promotion of healthy lifestyle | + | + | + | + | + | + | ||||
| Providing information about the possibility for the genetic testing | + | |||||||||
| Obligatory obstetrician consultation if care provided by a midwife | + | |||||||||
| Gathering data concerning the lifestyle and eating habits, including the consumption of alcohol and other stimulants | + | |||||||||
| Blood type, Rh | + | |||||||||
| Red blood cells antibody screen/antibodies | + | + | + | |||||||
| Complete blood count | + | + | + | + | ||||||
| General urine test | + | + | + | + | ||||||
| Cervical cytology test | + | |||||||||
| Fasting blood glucose or oral glucose tolerance test (OGTT) in women with risk factors for gestational diabetes mellites (GDM) | + | |||||||||
| Venereal disease research laboratory (VDRL) test | + | + | ||||||||
| Recommendation of dental consultation | + | |||||||||
| Human immunodeficiency virus (HIV) and the hepatitis C virus (HCV) tests | + | + | ||||||||
| Hepatitis B (HBS) antigen | + | |||||||||
| Toxoplasma gondii immunoglobulins test (IgG, IgM) without the presence of IgG antibodies before pregnancy | + | + | ||||||||
| Rubeola immunoglobulins test (IgG, IgM) if the woman has not been vaccinated | + | |||||||||
| Thyrotropin (TSH) level | + | |||||||||
| Body weight measurement | + | + | + | + | + | + | + | |||
| Assessing the risk of depression development and depression symptoms if occurred | + | + | ||||||||
| Ultrasound examination accordingly to the Polish Society of Gynecologists and Obstetricians (PTGiP) recommendations [ | + 2 | + 2 | + 2 | + 2 | ||||||
| Commencement of the antenatal | + 3 | |||||||||
| Fetal heart rate (FHR) assessment | + | + | + | + | + | |||||
| Obligatory obstetrician consultation in case of health care provided by a midwife | + | + | + | |||||||
| Fasting oral glucose tolerance test | + | |||||||||
| Oral glucose tolerance test (OGTT) | + | |||||||||
| Anti-D immunoglobulin administration | + | |||||||||
| Obstetric examination | + | |||||||||
| Pelvic dimensions assessment | + | |||||||||
| Fetal movement assessment | + | + | ||||||||
| Detection of a group B Streptococcus (GBS—vaginal and rectal swab) | + | |||||||||
| HCV test | + | |||||||||
| Cardiotocography (CTG) | + | |||||||||
| Others | + |
1. Many gynecological/midwifery clinics were closed for a few months, appointments were cancelled, laboratories were closed, and test results were delayed. 2. Only asymptomatic patients (without any cold/flu-like symptoms) with a negative history of COVID-19 should have ultrasounds. Patients with a negative epidemiological history, not feverish but with symptoms of an infection—postpone the examination until those symptoms will have disappeared. In mild cases, setting the deadline in 7 days is sufficient [8]. Modification of routine examination depending on COVID-19 infection status/screening positive for symptoms [9]. 3. Usually provided by midwives consociated in clinics. Meetings with parents were suspended for a long time, some midwives began online-led antenatal classes only [10].